The Jewish Hospital is one of three hospitals in the nation to earn the Joint Commission’s Gold Seal of Approval and certification for its leukemia care program. The recertification of The Jewish Hospital — Mercy Health Cincinnati Cancer and Cellular Therapy Center follows an onsite review that affirmed the hospital’s commitment to provide patients with high quality care.
“Learning you have leukemia is frightening for both patients and their families. We hope that this recognition of our leukemia care program as the most advanced, experienced and high performing adult blood and bone marrow transplant program in the Tri-State is a comfort to those receiving their care from us,” said Michael Kramer, president of The Jewish Hospital. “All credit goes to our dedicated care team, who achieved recertification by giving patients outcomes that compare with those of MD Anderson and Duke University.”
“The blood cancer experts at The Jewish Hospital and OHC have more experience in the care of acute leukemia than any other hospital or medical group in the region, making Mercy Health’s Cincinnati Cancer and Cellular Therapy Center the patient center of choice,” said OHC’s James Essell, MD, medical director of the Center, hematologist, medical oncologist, transplant and cellular therapy specialist.
“Leukemia Certification recognizes health care organizations committed to fostering continuous quality improvement in patient safety and quality of care,” says Mark Pelletier, RN, MS, chief operating officer, Accreditation and Certification Operations, and chief nursing executive, The Joint Commission. “We commend The Jewish Hospital for using certification to reduce variation in its clinical processes and to strengthen its program structure and management framework for leukemia patients.”
The Joint Commission’s standards are developed in consultation with health care experts and providers, measurement experts and patients. They are informed by scientific literature and expert consensus to help health care organizations measure, assess and improve performance. The surveyors also conducted onsite observations and interviews. For more information, please visit The Joint Commission website at www.jointcommission.org.Each year, thousands of people develop blood diseases, such as leukemia, Hodgkin’s disease, non-Hodgkin’s lymphoma and multiple myeloma that are treatable with blood stem cell or bone marrow transplants. The Jewish Hospital – Mercy Health is the Tri-State leader in blood cancers and has performed 2,200 bone marrow transplants since 1993. It performs more than 100 blood and bone marrow transplants each year. The Jewish Hospital was one of two hospitals in the nation to earn The Joint Commission’s Gold Seal of Approval® for Bone Marrow Transplant Certification in December 2021.